Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Ottawa

$28,000.00

Novel Gi signaling to the tumor necrosis factor-alpha death pathway

EF 2012-13

Résumé
We have discovered a novel cancer pathway mediated by inhibitory G proteins and propose to identify new signaling molecules that can prevent cell proliferation or tumor formation. Dopamine is an important hormone and neurotransmitter that works through the activation of inhibitory G proteins (Gi) to regulate cell growth and differentiation. We have investigated how dopamine causes tumors to form. We found that dopamine initiates a novel pathway that is mediated by a new class of growth regulators called TNFAIP8. By knocking down TNFAIP8 we showed that this pathway is essential for dopamine-induced transformation of cells to form tumors. We also found that dopamine inhibits cell death induced by death receptors, such as the tumor necrosis factor receptor. Death receptors are a key mechanism by which the body eliminates defective cells that could cause tumors. Interestingly, TNFAIP8 was also required for this action of dopamine. Taken together, we hypothesize that dopamine-mediated rescue of pre-oncogenic cells from cell death requires TNFAIP8 and enhances progression to oncogenic transformation. In this proposal we will further address how dopamine signalling to TNFAIP8 blocks death receptor actions, leading to cell survival and transformation. We will first test whether dopamine brings the TNFAIP8 protein to the death receptor to block its actions; then we will test which actions of the death receptor are affected by dopamine and TNFAIP8; finally we will look for the specific proteins that TNFAIP8 binds to in order to mediate its actions to prevent cell death. These studies will clarify how TNFAIP8 inhibits cell death, and may allow for the development of specific cancer therapeutic compounds to block TNFAIP8's anti-death actions, and to promote the death of cancer cells by the death receptors.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
228234-2012
Name nom
Albert, Paul
Department département
Neuroscience Research Institute
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
1
Nb partie
1
Application title
Novel Gi signaling to the tumor necrosis factor-alpha death pathway
Keyword
NSERC
Application summary
We have discovered a novel cancer pathway mediated by inhibitory G proteins and propose to identify new signaling molecules that can prevent cell proliferation or tumor formation. Dopamine is an important hormone and neurotransmitter that works through the activation of inhibitory G proteins (Gi) to regulate cell growth and differentiation. We have investigated how dopamine causes tumors to form. We found that dopamine initiates a novel pathway that is mediated by a new class of growth regulators called TNFAIP8. By knocking down TNFAIP8 we showed that this pathway is essential for dopamine-induced transformation of cells to form tumors. We also found that dopamine inhibits cell death induced by death receptors, such as the tumor necrosis factor receptor. Death receptors are a key mechanism by which the body eliminates defective cells that could cause tumors. Interestingly, TNFAIP8 was also required for this action of dopamine. Taken together, we hypothesize that dopamine-mediated rescue of pre-oncogenic cells from cell death requires TNFAIP8 and enhances progression to oncogenic transformation. In this proposal we will further address how dopamine signalling to TNFAIP8 blocks death receptor actions, leading to cell survival and transformation. We will first test whether dopamine brings the TNFAIP8 protein to the death receptor to block its actions; then we will test which actions of the death receptor are affected by dopamine and TNFAIP8; finally we will look for the specific proteins that TNFAIP8 binds to in order to mediate its actions to prevent cell death. These studies will clarify how TNFAIP8 inhibits cell death, and may allow for the development of specific cancer therapeutic compounds to block TNFAIP8's anti-death actions, and to promote the death of cancer cells by the death receptors.